US2007187405A1PendingUtilityA1

Container for compositions containing cefdinir

50
Individually held — no corporate assignee on recordPriority: Jan 23, 2006Filed: Jan 9, 2007Published: Aug 16, 2007
Est. expiryJan 23, 2026(expired)· nominal 20-yr term from priority
Inventors:Chetan P. PujaraDaniel KimShyamala Jayaraman
A61J 1/00A61K 9/145
50
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

Plastic containers for storage and preservation of compositions comprising cefdinir are disclosed.

Claims

exact text as granted — not AI-modified
1 . A plastic container having a closure device for storing and preserving compositions comprising sodium benzoate and cefdinir, wherein the percentage of the sodium benzoate or the cefdinir remains substantially unchanged over time.  
   
   
       2 . The plastic container of  claim 1 , wherein the cefdinir therein is cefdinir powder for reconstituted suspension.  
   
   
       3 . A plastic container having a closure device for storing and preserving compositions comprising sodium benzoate and cefdinir, wherein the cefdinir remains at least at about 90% of its original theoretical amount or the sodium benzoate remains at least at about 80% of its original theoretical amount.  
   
   
       4 . The plastic container of  claim 3 , wherein the cefdinir therein is cefdinir powder for reconstituted suspension.  
   
   
       5 . A plastic container having a closure device for storing and preserving pharmaceutical compositions comprising sodium benzoate and cefdinir, wherein, after 24 months, the cefdinir remains at least at about 90% of its original theoretical amount or the sodium benzoate remains at least at about 80% of its original theoretical amount.  
   
   
       6 . The plastic container of  claim 5 , wherein the cefdinir therein is cefdinir powder for reconstituted suspension.  
   
   
       7 . A polyethylene naphthylate container having a closure device for storing and preserving pharmaceutical compositions comprising sodium benzoate and cefdinir.  
   
   
       8 . The plastic container of  claim 7 , wherein the cefdinir therein is cefdinir powder for reconstituted suspension.  
   
   
       9 . A polyethylene naphthylate container having a closure device for storing and preserving pharmaceutical compositions comprising sodium benzoate and cefdinir, wherein the cefdinir remains at least at about 90% of its original theoretical amount or the sodium benzoate remains at least at about 80% of its original theoretical amount.  
   
   
       10 . The polyethylene naphthylate container of  claim 9 , wherein the cefdinir therein is cefdinir powder for reconstituted suspension.  
   
   
       11 . A polyethylene naphthylate container having a closure device for storing and preserving pharmaceutical compositions comprising sodium benzoate and cefdinir, wherein, after 24 months, the cefdinir remains at least at about 90% of its original theoretical amount or the sodium benzoate remains at least at about 80% of its original theoretical amount.  
   
   
       12 . The polyethylene naphthylate container of  claim 11 , wherein the cefdinir therein is cefdinir powder for reconstituted suspension.  
   
   
       13 . A cyclic olefin copolymer container having a closure device for storing and preserving pharmaceutical compositions comprising sodium benzoate and cefdinir.  
   
   
       14 . The cyclic olefin copolymer container of  claim 13 , wherein the cefdinir therein is cefdinir powder for reconstituted suspension.  
   
   
       15 . A cyclic olefin copolymer container having a closure device for storing and preserving pharmaceutical compositions comprising sodium benzoate and cefdinir, wherein the cefdinir remains at least at about 90% of its original theoretical amount or the sodium benzoate remains at least at about 80% of its original theoretical amount.  
   
   
       16 . The cyclic olefin copolymer container of  claim 15 , wherein the cefdinir therein is cefdinir powder for reconstituted suspension.  
   
   
       17 . A cyclic olefin copolymer container having a closure device for storing and preserving pharmaceutical compositions comprising sodium benzoate and cefdinir, wherein, after 24 months, the cefdinir remains at least at about 90% of its original theoretical amount or the sodium benzoate remains at least at about 80% of its original theoretical amount.  
   
   
       18 . The cyclic olefin copolymer container of  claim 17 , wherein the cefdinir therein is cefdinir powder for reconstituted suspension.  
   
   
       19 . A plastic container having a closure device for storing and preserving compositions comprising sodium benzoate and cefdinir, wherein the percentage of the sodium benzoate and the cefdinir remains substantially unchanged over time.  
   
   
       20 . The plastic container of  claim 19 , wherein the cefdinir therein is cefdinir powder for reconstituted suspension.  
   
   
       21 . A plastic container having a closure device for storing and preserving compositions comprising sodium benzoate and cefdinir, wherein the cefdinir remains at least at about 90% of its original theoretical amount and the sodium benzoate remains at least at about 80% of its original theoretical amount.  
   
   
       22 . The plastic container of  claim 21 , wherein the cefdinir therein is cefdinir powder for reconstituted suspension.  
   
   
       23 . A plastic container having a closure device for storing and preserving pharmaceutical compositions comprising sodium benzoate and cefdinir, wherein, after 24 months, the cefdinir remains at least at about 90% of its original theoretical amount and the sodium benzoate remains at least at about 80% of its original theoretical amount.  
   
   
       24 . The plastic container of  claim 23 , wherein the cefdinir therein is cefdinir powder for reconstituted suspension.  
   
   
       25 . A polyethylene naphthylate container having a closure device for storing and preserving pharmaceutical compositions comprising sodium benzoate and cefdinir.  
   
   
       26 . The polyethylene naphthylate container of  claim 25 , wherein the cefdinir therein is cefdinir powder for reconstituted suspension.  
   
   
       27 . A polyethylene naphthylate container having a closure device for storing and preserving pharmaceutical compositions comprising sodium benzoate and cefdinir, wherein the cefdinir remains at least at about 90% of its original theoretical amount and the sodium benzoate remains at least at about 80% of its original theoretical amount.  
   
   
       28 . The polyethylene naphthylate container of  claim 27 , wherein the cefdinir therein is cefdinir powder for reconstituted suspension.  
   
   
       29 . A polyethylene naphthylate container having a closure device for storing and preserving pharmaceutical compositions comprising sodium benzoate and cefdinir, wherein, after 24 months, the cefdinir remains at least at about 90% of its original theoretical amount and the sodium benzoate remains at least at about 80% of its original theoretical amount.  
   
   
       30 . The polyethylene naphthylate container of  claim 29 , wherein the cefdinir therein is cefdinir powder for reconstituted suspension.  
   
   
       31 . A cyclic olefin copolymer container having a closure device for storing and preserving pharmaceutical compositions comprising sodium benzoate and cefdinir.  
   
   
       32 . The cyclic olefin copolymer container of  claim 31 , wherein the cefdinir therein is cefdinir powder for reconstituted suspension.  
   
   
       33 . A cyclic olefin copolymer container having a closure device for storing and preserving pharmaceutical compositions comprising sodium benzoate and cefdinir, wherein the cefdinir remains at least at about 90% of its original theoretical amount and the sodium benzoate remains at least at about 80% of its original theoretical amount.  
   
   
       34 . The cyclic olefin copolymer container of  claim 33 , wherein the cefdinir therein is cefdinir powder for reconstituted suspension.  
   
   
       35 . A cyclic olefin copolymer container having a closure device for storing and preserving pharmaceutical compositions comprising sodium benzoate and cefdinir, wherein, after 24 months, the cefdinir remains at least at about 90% of its original theoretical amount and the sodium benzoate remains at least at about 80% of its original theoretical amount.  
   
   
       36 . The cyclic olefin copolymer container of  claim 35 , wherein the cefdinir therein is cefdinir powder for reconstituted suspension.

Join the waitlist — get patent alerts

Track US2007187405A1 — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.